Tag Archives: psychiatric medication

On the roles of the environment and FGF2 in anxiety

The Medical News recently posted and article entitled: Research suggests potential new treatment for anxiety disorders and depression. The article reviews the study A New Role for FGF2 as an Endogenous Inhibitor of Anxiety, which was published by The Journal of Neuroscience on May 13, 2009. The article reminds us that “(p)revious human studies…showed that

Kava for Anxiety?

Yesterday, May 11,

Treatments for Adolescent Depression

A new study takes a look at the effectiveness of various treatments for teenage depression. Unfortunately, I cannot give you a link to the article as it is on a subscription service. But here’s the citation for the article: Treatment of adolescent depression: what we have come to know Benedetto Vitiello, M.D Depression and Anxiety

More Lucre in Healthcare

The Boston Globe is reporting today that Dr. Joseph Biederman is “asking a judge to seal his testimony and accompanying documents in a huge multistate lawsuit, saying they “could be immensely damaging to him, both personally and professionally.” Dr. Biederman is professor of psychiatry at Harvard Medical School and Director of Massachusetts General Hospital’s Pediatric

Anxiety, PTSD and Propanolol

A recent study, Beyond extinction: erasing human fear responses and preventing the return of fear, is making a lot of headlines. I will go through the study in a moment. But first I want to make an observation from my clinical experience. A number of persons that I treated for anxiety disorders were on propanolol.

Treatments for Anxiety Disorders

This post will return to anxiety treatment topics. More specifically, I would like to address the issue of treatment approaches or techniques. As my earlier posts on this topic surely indicate, I am a strong adherent of cognitive behavioral therapy (CBT). However, in my experience, this is not always the beginning and end point of